SCHEMBL16073076

SCHEMBL16073076

O=C(Nc1nccs1)c1c(Cl)cc(Cl)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.58
RAB9A P51151 5/20 0.58
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
ALDH1A1 P00352 3/20 0.58
HPGD P15428 3/20 0.58
KCNMA1 Q12791 2/20 0.58
GCK P35557 1/20 0.57
SMN1; SMN2 Q16637 4/20 0.55
KDM4E B2RXH2 3/20 0.55
HTT P42858 2/20 0.55
POLB P06746 1/20 0.55
LMNA P02545 2/20 0.55
METAP2 P50579 1/20 0.55
METAP1 P53582 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
MAPT P10636 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16073042 0.88 NPC1 (0.58) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL27891117 0.84 NPC1 (0.63) NPC1RAB9AKMT2AMEN1ALDH1A1
Bromide SCHEMBL27908386 0.83 NPC1 (0.61) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL8797071 0.83 NPC1 (0.62) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL28801036 0.76 NPC1 (0.72) NPC1RAB9AKMT2AMEN1KCNMA1
SCHEMBL5733209 0.75 NPC1 (0.61) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL16073045 0.75 MGAM (0.55) NPC1RAB9AKMT2AMEN1ALDH1A1
Bromide SCHEMBL27908399 0.75 NPC1 (0.70) NPC1RAB9AKMT2AMEN1KCNMA1
SCHEMBL7693536 0.75 MAPT (0.74) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL27702357 0.74 NPC1 (0.72) NPC1RAB9AKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604946-B2 Methods for modulating bacterial virulence and related compounds THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-03-28 US disclosed
US-9604946-B2 Methods for modulating bacterial virulence and related compounds THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-03-28 US disclosed
US-20140275189-A1 Methods for Modulating Bacterial Virulence and Related Compounds THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-09-18 US disclosed
US-20140275189-A1 Methods for Modulating Bacterial Virulence and Related Compounds THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275189-A1 Methods for Modulating Bacterial Virulence and Related Compounds STAT1, MLEC, CGAS NPC1 3763/4885RAB9A 1509/4885KMT2A 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.